Trauma & major bleeding

Initiation of High‐Potency Benzodiazepine Prescriptions Among Survivors of Severe Trauma

Acta Anaesthesiol ScandPublished Population-based cohort study

Authors' conclusion

Trauma exposure independently predicted initiation of high-potency BZDs among previously BZD-naive patients. Psychiatric comorbidity, substance use, and greater injury severity were important risk factors.

Study context

Population
BZD-naive survivors of severe trauma, Sweden
Participants
12,206 vs 66,801
Exposure
Trauma exposure vs matched controls; new BZD use vs no new BZD use within the trauma cohort
  • Trauman = 12,206
  • Controlsn = 66,801reference
Outcome
New initiation of high-potency BZD prescriptions (at least one prescription filled)
Follow-up
Within 6 months after trauma
Methodological detailsmatched controls, regional trauma registry linked to Swedish national health registers
  • Matched controls
  • Regional trauma registry linked to Swedish national health registers

Main finding

As reported in the abstract

New high-potency BZD initiation
  • Trauma exposure independently associated with new high-potency BZD use

Observational data: associations, not effects.

Further findings

Mortality, new BZD use vs no new use (trauma cohort) · 6-18 months

aHR (95% CI)P value
New BZD use2.9 (2.0–4.2)P < 0.001

Risk factors for BZD initiation within the trauma cohort

Older age, psychiatric comorbidity, substance abuse, pre-traumatic opioid or sedative-hypnotic drug use, penetrating trauma, higher injury severity

Original publication

Initiation of High‐Potency Benzodiazepine Prescriptions Among Survivors of Severe Trauma. Acta Anaesthesiol Scand. Published 30 April 2026. doi:10.1111/aas.70245

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.